The only thing the FDA could do to stimulate vaccination, indicates the survey
Nearly half of people are considering vaccine say that it would allow them to get the covidity.
The vaccination process In the United States, had its fair share of bumps along the road, but now there is no little standing in the way of people from all over the country that get the shot Covid. Not only vaccination is free and appointment readily available, but there are three vaccines allowed for urgency use by Food and Drug Administration (FDA): Pfizer, Moderna and Johnson & Johnson. More than 50% of people in the United States have already receivedminus a dose a COVID vaccine, according to the latest data from disease control and prevention centers (CDC), but the vaccination rate in the country slows nowin the midst of the lack of demand, who had experts worried about the other half of the population. According to a new survey, the FDA could stimulate vaccination by providing full approval to a Covid vaccine - not only an emergency authorization.
RELATED:If you have this vaccine, you can not go back to campus, many colleges warn.
An investigation from the Kaiser Family Foundation revealed that nearHalf of non-vaccinated people In the United States, the United States is more likely to be vaccinated after the FDA approves a Covid vaccine. According to the published survey May 28, 44% of those who say they "are waiting for" "about a Covid vaccine would be more likely to get the shot if one of the currently authorized vaccines for urgency use receivedfull approval.
"Among various incentives tested in the monitor of this month, the one that seems to have the most resonance, especially for those to" wait and see ", is a complete approval of the FDA of one or more of the CVIV-19 vaccines , "The Kaiser Family Foundation explained in an article accompanying the investigation.
Pfizer and Moderna are the only two manufacturers who submitted a biology license application (BLA) to the FDA, which requires the FDA to consider at least six months of safety and efficiency data to approve a vaccine. Pfizerannounced its application For complete approval of people aged 16 and over May 7, while modern modernannounced his request For 18 years and over on June 1st. However,The New York Times say itprocess to approve These applications could take months.
RELATED:For more information up to date, sign up for our daily newsletter.
Health officials indicate that the expectation of the possibility of being vaccinated could harm the country's opportunity to contain Covid. "The more people who are unvaccinated, the more COVID virusMall to different guests, "Long cat, a spokesman for the Richmond-Henrico Health District, told CBS Affiliate WTVR. Long said it is also unlikely that everything changes in terms of the efficacy or side effects of the vaccine over the next six months, so the wait has not much meaning.
"The generally serious side effects occur within two months. We are doing the window in the tests and in the actual scenarios of life when people probably have a reaction," she explained.
William Moss, MD, Executive Director of the International Vaccine Access Center at the School of Hopkins Bloomberg of Johns Hopkins Public Health Public Health, said the same thing in ABC News, explaining that "there is nothingAbout this review process This will reveal everything we do not know. "
"Yes, it's a kind of official stamp of approval, but I do not think it really provides much more than what we already know," he said. "We have more vaccine safety data than with any other vaccine, even before the full approval review."
RELATED:99% of hospitalized people for COVID in 2021 have in common.